What’s New in the CTN?

Updates from the NIDA National Drug Abuse Treatment Clinical Trials Network. Want to share some news about your protocol, node, publications or presentations, or other CTN-related work here and/or in the CTN Bulletin? Email us at ctnlib@uw.edu!

NIDA INVEST Postdoctoral Fellowship International Scholars – Special Application Deadline: April 1, 2023

Yellow sticky note with black text reading APPLY NOW!

January 25, 2023 NIDA International Program is accepting applications for international postdoctoral researchers for the INVEST Drug Use and Addiction Research Fellowship. This combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug use and addiction scientists. Fellowship: The 12-month INVEST fellowship provides rigorous postdoctoral research training with a NIDA grantee at a U.S. institution, professional development activities that help establish personal relationships with NIDA grantees and NIDA officials, a stipend for living and personal expenses, and an allowance to cover…

CTN & ATTC Webinar: Digital Therapeutics in the Treatment of SUD (Feb 15, 11am PT

Digital Therapeutics in the Treatment of SUD (Feb 15, 11am PT). 1.5 CME/CE available.

February 15, 2023 | 11am-12:30pm PT | Register here! Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs,…

News from the Northeast Node: Science Series Update

Node News

January 8, 2023 Northeast Node Science Series kicks off its ’22-23 Academic Year with an in-depth review of cannabis as a potential pharmacological adjunct to MOUD In November 2022, the Northeast Node welcomed Dr. Ziva Cooper of the UCLA Center for Cannabis & Cannabinoids to kick off the Node’s ’22-23 Academic Year Science Series. Dr. Cooper’s presentation, “Cannabis and Opioids: Promising pharmacology to address the opioid epidemic?” gave a brief overview of cannabis and the pharmacology of phytocannabinoids. Preclinical studies and randomized controlled trials have examined the potential for cannabinoids…

New Articles from CTN-0049 (Project HOPE) and CTN-0073 (PROUD)

New in the Library

January 8, 2023 Added to the CTN Dissemination Library recently: Differential effects of patient navigation across latent profiles of barriers to care among people living with HIV and comorbid conditions.Traynor SM, et al. Journal of Clinical Medicine 2023;12:114. This paper reports on a study analyzing data from CTN-0049 (Project HOPE) to see if patient navigation interventions (with and without contingency management) are effective at increasing engagement in HIV care and viral suppression for people living with HIV. Find it in the CTN Dissemination Library. Baseline representativeness of patients in clinics…

Protocol News: CTN-0100

CTN-0100 Update

December 8, 2022 In November, the CTN-0100 Project Team launched a month-long BINGO challenge aimed at boosting recruitment across the 18 study sites. BINGO squares included hitting (or exceeding!) randomization targets for the month, reuniting with a missing participant, and completing internal QA. The Adapt site from the Western States Node and the SSTAR site from the New England Consortium Node were the first sites to “BINGO”, just 16 days into the challenge (see photos of the winning team below)! 7 additional sites achieved “BINGO” by the end of the…

Webinar: The Effectiveness & Utility of Telebehavioral (Telehealth) Services, Nov. 2, 11am PT

Photos of presenters

The goal of the National Institute of Drug Abuse (NIDA) Clinical Trials Network/Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting-edge science. This series is sponsored by the Western States Node of the CTN and the Pacific Northwest and Pacific Southwest ATTCs. The uptake in the use of telebehavioral services since the start of the Public Health Emergency (PHE) has been swift and is significantly transforming how behavioral health services are delivered. This is encouraging, as the research base…

News from the Florida Node Alliance

Photo of Dr. Szapocznik and text News from the FL Node: Dr. Jose Szapocznik elected to ASEMFL

Dr. José Szapocznik, Multiple PI of CTN’s Florida Node Alliance and Professor and Chair Emeritus at the Department of Public Health Sciences, of the University of Miami Miller School of Medicine, was elected to the Academy of Science, Engineering and Medicine of Florida (ASEMFL), an evidence-based scientific advisory body focused on providing expert advice to state government and other organizations on current and future challenges facing the world and Florida. Recognizing four and a half decades of important contributions to developing and testing interventions in the areas of mental health and…

Webinar: Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment (Sept 29, 2022)

The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual workshop titled “Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment.” This workshop is scheduled for Thursday, September 29, 2022, from 10:30 a.m.– 4:30 p.m. ET. This workshop aims to introduce these trending approaches; assess their strengths, limitations, and potential; discuss feasible research questions; identify study priorities, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research.  The workshop consists…